Eric Reiman is executive director of the Banner Alzheimer’s Institute, chief executive officer of Banner Research, clinical director of Neurogenomics at the Translational Genomics Research Institute, professor of psychiatry at the University of Arizona, university professor of neuroscience at Arizona State University, and director of the Arizona Alzheimer’s Consortium. He is leading the Platform for the Discovery of Alzheimer’s Disease Mechanisms and Treatments project.
Reiman received his undergraduate and medical degrees at Duke University (Durham, US) and his psychiatry residency training at both Duke and Washington University (St. Louis, US). Launching his research career as a resident and faculty member under Marcus Raichle, he and his colleagues introduced brain imaging paradigms and image analysis techniques that have had a profound impact on the study of the human mind and brain. Reiman and his Banner Alzheimer’s Institute colleagues, Pierre Tariot and Jessica Langbaum, lead the Alzheimer’s Prevention Initiative (API), which has helped to introduce a new era in Alzheimer’s prevention research. He is the author of more than 300 publications, a principal investigator of several large NIH grants and a recipient of the Potamkin Prize.
Reiman is internationally recognized for his pioneering contributions in brain imaging, genomics, and the cognitive and behavioral neurosciences; the unusually early detection and tracking of Alzheimer’s disease; and the accelerated evaluation of Alzheimer’s prevention therapies. He and his colleagues hope to provide the evidence needed to help establish a new national standard of dementia care by 2020 and to find and support the approval of effective Alzheimer’s prevention therapies by 2025. They continue to find new ways for researchers from different disciplines and organizations to work together in support of their ambitious goals.
Platform for the Discovery of Alzheimer’s Disease Mechanisms and Treatments
NOMIS RESEARCH PROJECT
A 73-Year-Old-Woman Who Should Have Gotten Alzheimer’s, Didn’t—Revitalizing a Search for the Cure
Eric Reiman, Oskar Hanson and colleagues: New blood test shows great promise in the diagnosis of Alzheimer’s disease
NOMIS scientist Eric Reiman and team reveal new insights into Alzheimer’s disease
The collaborator: NOMIS researcher Eric Reiman is on a quest to prevent Alzheimer’s disease by sharing big data
Advancing science needs out-of-the box thinking